DNMT3A and myeloid neoplasm: In general, the presence of DNMT3A mutations in patients with myeloid malignancies has been associated with a higher number of blasts in BM and greater leukocyte counts in blood [124,134] in the absence of a clear prognostic impact [134,137,138,139].